NO20000330D0 - Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein - Google Patents

Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Info

Publication number
NO20000330D0
NO20000330D0 NO20000330A NO20000330A NO20000330D0 NO 20000330 D0 NO20000330 D0 NO 20000330D0 NO 20000330 A NO20000330 A NO 20000330A NO 20000330 A NO20000330 A NO 20000330A NO 20000330 D0 NO20000330 D0 NO 20000330D0
Authority
NO
Norway
Prior art keywords
lipid
protein
preparation
articles
pharmaceutical compositions
Prior art date
Application number
NO20000330A
Other languages
English (en)
Other versions
NO20000330L (no
Inventor
Matthias Andersson
Dorota Johansson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000330D0 publication Critical patent/NO20000330D0/no
Publication of NO20000330L publication Critical patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000330A 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein NO20000330L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
PCT/SE1998/001407 WO1999004761A1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein

Publications (2)

Publication Number Publication Date
NO20000330D0 true NO20000330D0 (no) 2000-01-21
NO20000330L NO20000330L (no) 2000-03-21

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Country Status (12)

Country Link
EP (1) EP1014947B1 (no)
JP (1) JP3813439B2 (no)
AT (1) ATE289806T1 (no)
AU (1) AU744738B2 (no)
CA (1) CA2297924C (no)
DE (1) DE69829191T2 (no)
ES (1) ES2236919T3 (no)
NO (1) NO20000330L (no)
NZ (1) NZ502840A (no)
PT (1) PT1014947E (no)
SE (1) SE9702776D0 (no)
WO (1) WO1999004761A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1574210B1 (en) 1999-02-26 2016-04-06 Novartis Vaccines and Diagnostics, Inc. Microemulsions with adsorbed macromolecules
EP1154807A1 (en) * 1999-12-22 2001-11-21 Surgical Sealants, Incorporated Methods and compositions for sealing tissue leaks
DE60131927D1 (de) * 2000-02-02 2008-01-31 Univ Florida State Res Found Heterosubstituierte taxan-c10-acetate als antitumormittel
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
AU5711501A (en) * 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
US6599441B1 (en) 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
CN101284136A (zh) 2002-12-03 2008-10-15 布朗歇特洛克菲勒神经科学研究所 传输物质穿过血脑屏障的人工低密度脂蛋白载体
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
CA2521051C (en) 2003-04-04 2012-03-20 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
WO2006082824A1 (ja) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. マトリックス型腸溶性・徐放性組成物
US7951396B2 (en) * 2005-03-28 2011-05-31 Regeron, Inc. Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome
EP1979410B1 (en) * 2005-12-29 2012-08-22 Life Technologies Corporation Compositions and methods for improving resolution of biomolecules separated on polyacrylamide gels
EP1915986A1 (en) 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Lipid growth factor formulations
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
WO2011025036A1 (ja) * 2009-08-31 2011-03-03 ナノキャリア株式会社 粒子組成物及びこれを有する医薬組成物
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
ES2236919T3 (es) 2005-07-16
AU744738B2 (en) 2002-02-28
ATE289806T1 (de) 2005-03-15
WO1999004761A1 (en) 1999-02-04
DE69829191T2 (de) 2005-07-21
JP3813439B2 (ja) 2006-08-23
PT1014947E (pt) 2005-05-31
CA2297924A1 (en) 1999-02-04
AU8371898A (en) 1999-02-16
DE69829191D1 (de) 2005-04-07
JP2001510786A (ja) 2001-08-07
CA2297924C (en) 2007-04-10
NO20000330L (no) 2000-03-21
NZ502840A (en) 2002-08-28
EP1014947B1 (en) 2005-03-02
SE9702776D0 (sv) 1997-07-22
EP1014947A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
NO20000330D0 (no) Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
HUT38892A (en) Process for preparing alpha-, omega-dicarboxylic acids and pharmaceutical compositions comprising the same as active substance
AU1887999A (en) Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
ZA961898B (en) Novel melatonin-antagonist beta-carboline derivatives and analogues thereof containing naphthalenic structure process for their preparation and their medicinal products
DZ2414A1 (fr) 2-amino-6-(2-substitué-4-phenoxy)substituté-pyridines procédé pour leur préparation et compositions pharmaceutiques les contenant.
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
NO965388L (no) Fremgangsmåte og apparat for fremstilling av raskt opplöselige doseenheter og produkter derav
AU5212093A (en) Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same
FR2553409B1 (fr) Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
FI904474A0 (fi) Rekombinanta aprotininvarianter, gentekniskt foerfarande foer framstaellning av homogent processerade aprotininvarianter och deras terapeutiska anvaendning.
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
DE3768084D1 (de) Rekonstituiertes nahrungsmittel, verfahren und mischer zu seiner herstellung.
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
HUP0100277A2 (hu) 2,3,4,5-Tetrahidro-1H-[1,4]benzodiazepin-3-hidroxámsav-származékok mint metalloproteináz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
DZ1937A1 (fr) Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procédé pour les préparer.
JPH10109924A (ja) 美白化粧品
DE59604441D1 (de) Verfahren zur schonenden keimreduzierung von pharmazeutischen zubereitungen
FR2595703B1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application